Download PDF
Aktuelle Neurologie 2013; 40(03): 147-165
DOI: 10.1055/s-0032-1333014
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Kognitive Beeinträchtigungen bei Multipler Sklerose

Stand der Forschung und methodische GesichtspunkteCognitive Impairment in Multiple SclerosisState of Research and Methodological Issues
Y. Lembach
Institut für Studien zur Psychischen Gesundheit (ISPG), Mannheim
,
G. Adler
Institut für Studien zur Psychischen Gesundheit (ISPG), Mannheim
› Author Affiliations
Further Information

Publication History

Publication Date:
10 April 2013 (online)

Also available at
    Permissions and Reprints

Lernziele

  • Häufigkeit, Art und Bedeutung kognitiver Beeinträchtigungen bei MS einordnen können

  • Zusammenhänge mit Erkrankungsdauer, körperlichen Symptomen, Verlaufstyp und psychologischen Aspekten erfahren

  • nähere Informationen zu den häufig beeinträchtigten kognitiven Funktionen erwerben

  • Überblick über den aktuellen Stand der neuropsychologischen Diagnostik bei MS gewinnen; wissen, zu welchem Zweck welche Verfahren eingesetzt werden können und auf welche Probleme geachtet werden sollte

  • erfahren, wie sich kognitive Defizite in MRT-Befunden widerspiegeln können

  • Informationen zu Behandlungsmöglichkeiten erhalten

 

  • Literatur

  • 1 Charcot J. Lectures on the diseases of the nervous system. London: The New Sydenham Society; 1877
    Google Scholar
  • 2 Messinis L, Kosmidis MH, Lyros E et al. Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Int Rev Psychiatry 2010; 22: 22-34
    CrossrefPubMedGoogle Scholar
  • 3 Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151
    CrossrefPubMedGoogle Scholar
  • 4 Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev Neurother 2008; 8: 1585-1596
    CrossrefPubMedGoogle Scholar
  • 5 Patti F, Amato MP, Trojano M et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779-788
    CrossrefPubMedGoogle Scholar
  • 6 Nocentini U, Pasqualetti P, Bonavita S et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Mult Scler 2006; 12: 77-87
    CrossrefPubMedGoogle Scholar
  • 7 Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003; 16: 283-288
    CrossrefPubMedGoogle Scholar
  • 8 Engel C, Greim B, Zettl UK. Diagnostics of cognitive dysfunctions in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/30-II/34
    PubMedGoogle Scholar
  • 9 Amato MP, Portaccio E, Goretti B et al. Cognitive impairment in early stages of multiple sclerosis. Neurol Sci 2010; 31 (Suppl. 02) S211-S214
    CrossrefPubMedGoogle Scholar
  • 10 Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74: 443-446
    CrossrefPubMedGoogle Scholar
  • 11 Deloire MSA, Salort E, Bonnet M et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 519-526
    CrossrefPubMedGoogle Scholar
  • 12 Schulz D, Kopp B, Kunkel A et al. Cognition in the early stage of multiple sclerosis. J Neurol 2006; 253: 1002-1010
    CrossrefPubMedGoogle Scholar
  • 13 Prakash RS, Snook EM, Lewis JM et al. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler 2008; 14: 1250-1261
    CrossrefPubMedGoogle Scholar
  • 14 Feuillet L, Reuter F, Audoin B et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2007; 13: 124-127
    CrossrefPubMedGoogle Scholar
  • 15 Glanz BI, Holland CM, Gauthier SA et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007; 13: 1004-1010
    CrossrefPubMedGoogle Scholar
  • 16 Potagas C, Giogkaraki E, Koutsis G et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267: 100-106
    CrossrefPubMedGoogle Scholar
  • 17 Khalil M, Enzinger C, Langkammer C et al. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011; 17: 173-180
    CrossrefPubMedGoogle Scholar
  • 18 Tinnefeld M, Treitz FH, Haase CG et al. Attention and memory dysfunctions in mild multiple sclerosis. Eur Arch Psychiatry Clin Neurosci 2005; 255: 319-326
    CrossrefPubMedGoogle Scholar
  • 19 Zipoli V, Goretti B, Hakiki B et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 2010; 16: 62-67
    CrossrefPubMedGoogle Scholar
  • 20 Olazarán J, Cruz I, Benito-León J et al. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study. Eur Neurol 2009; 61: 87-93
    CrossrefPubMedGoogle Scholar
  • 21 Jonsson A, Andresen J, Storr L et al. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci 2006; 245: 77-85
    CrossrefPubMedGoogle Scholar
  • 22 Amato MP, Ponziani G, Siracusa G et al. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606
    CrossrefPubMedGoogle Scholar
  • 23 Achiron A, Barak Y. Cognitive changes in early ms: a call for a common framework. J Neurol Sci 2006; 245: 47-51
    CrossrefPubMedGoogle Scholar
  • 24 Smestad C, Sandvik L, Landrø NI et al. Cognitive impairment after three decades of multiple sclerosis. Eur J Neurol 2010; 17: 499-505
    CrossrefPubMedGoogle Scholar
  • 25 Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Mult Scler 2005; 11: 469-476
    CrossrefPubMedGoogle Scholar
  • 26 Brissart H, Morele E, Baumann C et al. Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both?. Neurol Sci 2012; 33: 1117-1123
    CrossrefPubMedGoogle Scholar
  • 27 Thornton AE, Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997; 11: 357-366
    CrossrefPubMedGoogle Scholar
  • 28 Piras MR, Magnano I, Canu EDG et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003; 74: 878-885
    CrossrefPubMedGoogle Scholar
  • 29 Schwid SR, Goodman AD, Weinstein A et al. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci 2007; 255: 57-63
    CrossrefPubMedGoogle Scholar
  • 30 Bergendal G, Fredrikson S, Almkvist O. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Eur Neurol 2007; 57: 193-202
    CrossrefPubMedGoogle Scholar
  • 31 Kujala P, Portin R, Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997; 120: 289-297
    CrossrefPubMedGoogle Scholar
  • 32 Camp SJ, Stevenson VL, Thompson AJ et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005; 128: 2891-2898
    CrossrefPubMedGoogle Scholar
  • 33 Glanz BI, Healy BC, Hviid LE et al. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry 2011; 83: 38-42
    PubMedGoogle Scholar
  • 34 Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci 2007; 14: 919-927
    CrossrefPubMedGoogle Scholar
  • 35 Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244-249
    CrossrefPubMedGoogle Scholar
  • 36 Beatty WW, Goodkin DE, Hertsgaard D et al. Clinical and demographic predictors of cognitive performance in multiple sclerosis: do diagnostic type, disease duration, and disability matter?. Arch Neurol 1990; 47: 305-308
    CrossrefPubMedGoogle Scholar
  • 37 Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009; 15: 2-8
    CrossrefPubMedGoogle Scholar
  • 38 Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 2006; 245: 169-175
    CrossrefPubMedGoogle Scholar
  • 39 Benedict RHB, Bruce JM, Dwyer MG et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63: 1301-1306
    CrossrefPubMedGoogle Scholar
  • 40 Denney DR, Lynch SG, Parmenter BA. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. J Neurol Sci 2008; 267: 129-136
    CrossrefPubMedGoogle Scholar
  • 41 Glad SB, Nyland H, Aarseth JH et al. How long can you keep working with benign multiple sclerosis?. J Neurol Neurosurg Psychiatry 2011; 82: 78-82
    CrossrefPubMedGoogle Scholar
  • 42 Portaccio E, Stromillo ML, Goretti B et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009; 73: 498-503
    CrossrefPubMedGoogle Scholar
  • 43 Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 2000; 15: 115-136
    CrossrefPubMedGoogle Scholar
  • 44 Goldhammer F, Moosbrugger H. Aufmerksamkeit. In: Schweizer K, Hrsg. Leistung und Leistungsdiagnostik. Heidelberg: Springer; 2006: 16-33
    CrossrefGoogle Scholar
  • 45 Denney DR, Hughes AJ, Owens EM et al. Deficits in planning time but not performance in patients with multiple sclerosis. Arch Clin Neuropsychol 2012; 27: 148-158
    CrossrefPubMedGoogle Scholar
  • 46 Denney DR, Lynch SG, Parmenter BA et al. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J Int Neuropsychol Soc 2004; 10: 948-956
    PubMedGoogle Scholar
  • 47 Tinnefeld M, Wilhelm H, Daum I et al. Kognitive Defizite in frühen Stadien der schubförmigen multiplen Sklerose. Akt Neurol 2008; 35: 2-7
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Callanan MM, Logsdail SJ, Ron MA et al. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. Brain 1989; 112: 361-374
    CrossrefPubMedGoogle Scholar
  • 49 McCarthy M, Beaumont JG, Thompson R et al. Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 705-718
    CrossrefPubMedGoogle Scholar
  • 50 De Sonneville LMJ, Boringa JB, Reuling IEW et al. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002; 40: 1751-1765
    CrossrefPubMedGoogle Scholar
  • 51 Denney DR, Gallagher KS, Lynch SG. Deficits in processing speed in patients with multiple sclerosis: evidence from explicit and covert measures. Arch Clin Neuropsychol 2011; 26: 110-119
    CrossrefPubMedGoogle Scholar
  • 52 Demaree HA, DeLuca J, Gaudino EA et al. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 1999; 67: 661-663
    CrossrefPubMedGoogle Scholar
  • 53 DeLuca J, Chelune GJ, Tulsky DS et al. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?. J Clin Exp Neuropsychol 2004; 26: 550-562
    CrossrefPubMedGoogle Scholar
  • 54 Denney DR, Lynch SG. The impact of multiple sclerosis on patients’ performance on the Stroop Test: processing speed versus interference. J Int Neuropsychol Soc 2009; 15: 451-458
    CrossrefPubMedGoogle Scholar
  • 55 Hoffmann S, Tittgemeyer M, Von Cramon DY. Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007; 20: 275-280
    CrossrefPubMedGoogle Scholar
  • 56 Olivares T, Nieto A, Sánchez MP et al. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis. Mult Scler 2005; 11: 191-197
    CrossrefPubMedGoogle Scholar
  • 57 Macniven JAB, Davis C, HO MY et al. Stroop performance in multiple sclerosis: information processing, selective attention, or executive functioning?. J Int Neuropsychol Soc 2008; 14: 805-814
    PubMedGoogle Scholar
  • 58 Lengenfelder J, Bryant D, Diamond BJ et al. Processing speed interacts with working memory efficiency in multiple sclerosis. Arch Clin Neuropsychol 2006; 21: 229-238
    CrossrefPubMedGoogle Scholar
  • 59 Litvan I, Grafman J, Vendrell P et al. Multiple memory deficits in patients with multiple sclerosis: exploring the working memory system. Arch Neurol 1988; 45: 607-610
    CrossrefPubMedGoogle Scholar
  • 60 Parmenter BA, Shucard JL, Shucard DW et al. Information processing deficits in multiple sclerosis: a matter of complexity. J Int Neuropsychol Soc 2007; 13: 417-423
    PubMedGoogle Scholar
  • 61 Arnett PA. Speed of presentation influences story recall in college students and persons with multiple sclerosis. Arch Clin Neuropsychol 2004; 19: 507-523
    CrossrefPubMedGoogle Scholar
  • 62 Leavitt VM, Lengenfelder J, Moore NB et al. The relative contributions of processing speed and cognitive load to working memory accuracy in multiple sclerosis. J Clin Exp Neuropsychol 2011; 33: 580-586
    CrossrefPubMedGoogle Scholar
  • 63 Winkelmann A, Engel C, Apel A et al. Cognitive impairment in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/35-II/42
    PubMedGoogle Scholar
  • 64 Paul RH, Blanco CR, Hames KA et al. Autobiographical memory in multiple sclerosis. J Int Neuropsychol Soc 1997; 3: 246-251
    PubMedGoogle Scholar
  • 65 Kenealy PM, Beaumont GJ, Lintern T et al. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22: 125-131
    CrossrefPubMedGoogle Scholar
  • 66 Demaree HA, Gaudino EA, DeLuca J et al. Learning impairment is associated with recall ability in multiple sclerosis. J Clin Exp Neuropsychol 2000; 22: 865-873
    CrossrefPubMedGoogle Scholar
  • 67 Rao SM, Leo GJ, Aubin-Faubert PS. On the nature of memory disturbance in multiple sclerosis. J Clin Exp Neuropsychol 1989; 11: 699-712
    CrossrefPubMedGoogle Scholar
  • 68 DeLuca J, Barbieri-Berger S, Johnson SK. The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 1994; 16: 183-189
    CrossrefPubMedGoogle Scholar
  • 69 Thornton AE, Raz N, Tucker KA. Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 2002; 8: 395-409
    CrossrefPubMedGoogle Scholar
  • 70 Müller SV, George S, Hildebrandt H et al. Leitlinie zur Diagnostik und Therapie von exekutiven Dysfunktionen. Z Neuropsychol 2010; 21: 167-176
    CrossrefPubMedGoogle Scholar
  • 71 Seiferth NY, Thienel R, Kircher T. Exekutive Funktionen. In: Schneider S, Fink R, Hrsg. Funktionelle MRT in Psychiatrie und Neurologie. Heidelberg: Springer; 2007: 265-277
    CrossrefGoogle Scholar
  • 72 Drew M, Tippett LJ, Starkey NJ et al. Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol 2008; 23: 1-19
    CrossrefPubMedGoogle Scholar
  • 73 Hildebrandt H, Brokate B, Lanz M et al. Exekutivfunktionsleistungen bei Patienten mit multipler Sklerose. Akt Neurol 2003; 30: 118-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Roca M, Torralva T, Meli F et al. Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts. Mult Scler 2008; 14: 364-369
    CrossrefPubMedGoogle Scholar
  • 75 Drew MA, Starkey NJ, Isler RB. Examining the link between information processing speed and executive functioning in multiple sclerosis. Arch Clin Neuropsychol 2009; 24: 47-58
    CrossrefPubMedGoogle Scholar
  • 76 Henry JD, Beatty WW. Verbal fluency deficits in multiple sclerosis. Neuropsychologia 2006; 44: 1166-1174
    CrossrefPubMedGoogle Scholar
  • 77 Connick P, Kolappan M, Bak TH et al. Verbal fluency as a rapid screening test for cognitive impairment in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2012; 83: 346-347
    CrossrefPubMedGoogle Scholar
  • 78 Kleeberg J, Bruggimann L, Annoni JM et al. Altered decision-making in multiple sclerosis: a sign of impaired emotional reactivity?. Ann Neurol 2004; 56: 787-795
    CrossrefPubMedGoogle Scholar
  • 79 Nagy H, Bencsik K, Rajda CÍL et al. The effects of reward and punishment contingencies on decision-making in multiple sclerosis. J Int Neuropsychol Soc 2006; 12: 559-565
    PubMedGoogle Scholar
  • 80 Simioni S, Ruffieux C, Kleeberg J et al. Preserved decision making ability in early multiple sclerosis. J Neurol 2008; 255: 1762-1769
    CrossrefPubMedGoogle Scholar
  • 81 Simioni S, Ruffieux C, Kleeberg J et al. Progressive decline of decision-making performances during multiple sclerosis. J Int Neuropsychol Soc 2009; 15: 291-295
    CrossrefPubMedGoogle Scholar
  • 82 Vleugels L, Lafosse C, van Nunen A et al. Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks. Mult Scler 2000; 6: 241-254
    CrossrefPubMedGoogle Scholar
  • 83 Rao SM, Leo GJ, Bernardin L et al. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691
    CrossrefPubMedGoogle Scholar
  • 84 Grossman M, Robinson KM, Onishi K et al. Sentence comprehension in multiple sclerosis. Acta Neurol Scand 1995; 92: 324-331
    PubMedGoogle Scholar
  • 85 Ghaffar O, Feinstein A. APOE epsilon4 and cognitive dysfunction in multiple sclerosis: a review. J Neuropsychiatry Clin Neurosci 2010; 22: 155-165
    CrossrefPubMedGoogle Scholar
  • 86 Carmona O, Masuet C, Santiago O et al. Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?. Acta Neurol Scand 2011; 124: 258-263
    CrossrefPubMedGoogle Scholar
  • 87 Perneczky R, Alexopoulos P, Schmid G et al. Kognitive Reservekapazität und ihre Bedeutung für Auftreten und Verlauf der Demenz. Nervenarzt 2011; 82: 325-335
    CrossrefPubMedGoogle Scholar
  • 88 Sumowski JF, Chiaravalloti N, DeLuca J. Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsychol 2009; 31: 913-926
    CrossrefPubMedGoogle Scholar
  • 89 Sumowski JF, Wylie GR, Chiaravalloti N et al. Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology 2010; 74: 1942-1945
    CrossrefPubMedGoogle Scholar
  • 90 Sumowski JF, Wylie GR, Gonnella A et al. Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis. Neurology 2010; 75: 1428-1431
    CrossrefPubMedGoogle Scholar
  • 91 Benedict R, Morrow S, Weinstock Guttman B et al. Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients. J Int Neuropsychol Soc 2010; 16: 829-835
    CrossrefPubMedGoogle Scholar
  • 92 Sumowski JF, Wylie GR, DeLuca J et al. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain 2010; 133: 362-374
    CrossrefPubMedGoogle Scholar
  • 93 Arnett PA. Does cognitive reserve apply to multiple sclerosis?. Neurology 2010; 74: 1934-1935
    CrossrefPubMedGoogle Scholar
  • 94 Pierson SH, Griffith N. Treatment of cognitive impairment in multiple sclerosis. Behav Neurol 2006; 17: 53-67
    CrossrefPubMedGoogle Scholar
  • 95 Benedict RHB, Fischer JS, Archibald CJ et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381-397
    CrossrefPubMedGoogle Scholar
  • 96 Ferreira MLB. Cognitive deficits in multiple sclerosis: a systematic review. Arq Neuropsiquiatr 2010; 68: 632-641
    CrossrefPubMedGoogle Scholar
  • 97 Foong J, Rozewicz L, Quaghebeur G et al. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 1998; 64: 529-532
    CrossrefPubMedGoogle Scholar
  • 98 Morrow SA, Jurgensen S, Forrestal F et al. Effects of acute relapses on neuropsychological status in multiple sclerosis patients. J Neurol 2011; 258: 1603-1608
    CrossrefPubMedGoogle Scholar
  • 99 Scherer P. Cognitive screening in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) II/26-II/29
    CrossrefPubMedGoogle Scholar
  • 100 Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis: an evaluation of the Mini-Mental State Examination. Arch Neurol 1990; 47: 297-301
    CrossrefPubMedGoogle Scholar
  • 101 Scherer P, Baum K, Bauer H et al. Normierung der Brief Repeatable Battery of Neuropsychological Tests (BRB-N) für den deutschsprachigen Raum. Nervenarzt 2004; 75: 984-990
    CrossrefPubMedGoogle Scholar
  • 102 Tombaugh TN. A comprehensive review of the paced auditory serial addition test (PASAT). Arch Clin Neuropsychol 2006; 21: 53-76
    CrossrefPubMedGoogle Scholar
  • 103 Rosti E, Hämäläinen P, Koivisto K et al. PASAT in detecting cognitive impairment in relapsing-remitting MS. Appl Neuropsychol 2007; 14: 101-112
    CrossrefPubMedGoogle Scholar
  • 104 Younes M, Hill J, Quinless J et al. Internet-based cognitive testing in multiple sclerosis. Mult Scler 2007; 13: 1011-1019
    CrossrefPubMedGoogle Scholar
  • 105 Deloire MSA, Bonnet MC, Salort E et al. How to detect cognitive dysfunction at early stages of multiple sclerosis?. Mult Scler 2006; 12: 445-452
    CrossrefPubMedGoogle Scholar
  • 106 Aupperle RL, Beatty WW, Shelton FdeNap. Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler 2002; 8: 382-389
    CrossrefPubMedGoogle Scholar
  • 107 Brooks JBB, Giraud VO, Saleh YJ et al. Paced auditory serial addition test (PASAT): a very difficult test even for individuals with high intellectual capability. Arq Neuropsiquiatr 2011; 69: 482-484
    CrossrefPubMedGoogle Scholar
  • 108 Drake AS, Weinstock-Guttman B, Morrow SA et al. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010; 16: 228-237
    CrossrefPubMedGoogle Scholar
  • 109 Forn C, Belenguer A, Belloch V et al. Anatomical and functional differences between the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test. J Clin Exp Neuropsychol 2011; 33: 42-50
    CrossrefPubMedGoogle Scholar
  • 110 Gow AJ, Deary IJ. Is the PASAT past it? Testing attention and concentration without numbers. J Clin Exp Neuropsychol 2004; 26: 723-736
    CrossrefPubMedGoogle Scholar
  • 111 Rao SM. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. New York: National Multiple Sclerosis Society; 1990
    Google Scholar
  • 112 Amato MP, Portaccio E, Goretti B et al. The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787-793
    CrossrefPubMedGoogle Scholar
  • 113 Buschke H. Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior 1973; 12: 543-550
    CrossrefPubMedGoogle Scholar
  • 114 Göhler H. Zwei neuropsychologische Testbatterien als Screeningtests bei sekundär progredienter Multipler Sklerose – Vergleich mit einem Normkollektiv. Freie Universität Berlin, Universitätsbibliothek; 2005
    Google Scholar
  • 115 Schultheis MT, Weisser V, Ang J et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil 2010; 91: 465-473
    CrossrefPubMedGoogle Scholar
  • 116 Boringa JB, Lazeron RHC, Reuling IEW et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7: 263-267
    CrossrefPubMedGoogle Scholar
  • 117 Strober L, Englert J, Munschauer F et al. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009; 15: 1077-1084
    CrossrefPubMedGoogle Scholar
  • 118 Portaccio E, Goretti B, Zipoli G et al. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol 2009; 23: 268-275
    CrossrefPubMedGoogle Scholar
  • 119 Benedict RHB, Cookfair D, Gavett R et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549-558
    PubMedGoogle Scholar
  • 120 Benedict RHB, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol 2007; 254 (Suppl. 02) II/22-II/25
    PubMedGoogle Scholar
  • 121 Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung: TAP (Version 2.2). Herzogenrath: Psytest; 2009
    Google Scholar
  • 122 Powlishta KK, Von Dras DD, Stanford A et al. The clock drawing test is a poor screen for very mild dementia. Neurology 2002; 59: 898-903
    CrossrefPubMedGoogle Scholar
  • 123 Ehreke L, Luppa M, König HH et al. Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr 2010; 22: 56-63
    CrossrefPubMedGoogle Scholar
  • 124 Barak Y, Lavie M, Achiron A. Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. J Clin Neurosci 2002; 9: 629-632
    CrossrefPubMedGoogle Scholar
  • 125 Scherer P, Penner IK, Rohr A et al. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study. Mult Scler 2007; 13: 402-411
    CrossrefPubMedGoogle Scholar
  • 126 Parmenter BA, Zivadinov R, Kerenyi L et al. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis. J Clin Exp Neuropsychol 2007; 29: 215-223
    CrossrefPubMedGoogle Scholar
  • 127 Gansler DA, Jerram MW, Vannorsdall TD et al. Does the Iowa Gambling Task measure executive function?. Arch Clin Neuropsychol 2011; 26: 706-717
    CrossrefPubMedGoogle Scholar
  • 128 Sanfilipo MP, Benedict RHB, Weinstock-Guttman B et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66: 685-692
    CrossrefPubMedGoogle Scholar
  • 129 Ciccarelli O, Chen JT. MS cortical lesions on double inversion recovery MRI. Neurology 2012; 78: 296-297
    CrossrefPubMedGoogle Scholar
  • 130 Seewann A, Kooi EJ, Roosendaal S et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302-308
    CrossrefPubMedGoogle Scholar
  • 131 Horakova D, Kalincik T, Dusankova JB et al. Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol 2012; 12: 10
    CrossrefPubMedGoogle Scholar
  • 132 Roosendaal SD, Bendfeldt K, Vrenken H et al. Grey matter volume in a large cohort of ms patients: relation to MRI parameters and disability. Mult Scler 2011; 17: 1098-1106
    CrossrefPubMedGoogle Scholar
  • 133 Calabrese M, Atzori M, Bernardi V et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212-1220
    CrossrefPubMedGoogle Scholar
  • 134 Amato M, Bartolozzi M, Zipoli V et al. Neocortical volume decrease in relapsing-remitting ms patients with mild cognitive impairment. Neurology 2004; 63: 89-93
    CrossrefPubMedGoogle Scholar
  • 135 Roosendaal S, Moraal B, Pouwels P et al. Accumulation of cortical lesions in ms: relation with cognitive impairment. Mult Scler 2009; 15: 708-714
    CrossrefPubMedGoogle Scholar
  • 136 Calabrese M, Agosta F, Rinaldi F et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144-1150
    CrossrefPubMedGoogle Scholar
  • 137 Kutzelnigg A, Lucchinetti CF, Stadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712
    CrossrefPubMedGoogle Scholar
  • 138 Benedict RHB, Ramasamy D, Munschauer F et al. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201-206
    CrossrefPubMedGoogle Scholar
  • 139 Sicotte N, Kern K, Giesser B et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131: 1134-1141
    CrossrefPubMedGoogle Scholar
  • 140 Geurts JJG, Bö L, Roosendaal SD et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66: 819-827
    CrossrefPubMedGoogle Scholar
  • 141 Lazeron RHC, de Sonneville LMJ, Scheltens P et al. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler 2006; 12: 760-768
    CrossrefPubMedGoogle Scholar
  • 142 Batista S, Zivadinov R, Hoogs M et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012; 259: 139-146
    CrossrefPubMedGoogle Scholar
  • 143 Fisher E, Lee JC, Nakamura K et al. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-265
    CrossrefPubMedGoogle Scholar
  • 144 Benedict RHB, Wahlig E, Bakshi R et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29-34
    CrossrefPubMedGoogle Scholar
  • 145 Hoogs M, Kaur S, Smerbeck A et al. Cognition and physical disability in predicting health-related quality of life in multiple sclerosis. Int J MS Care 2011; 13: 57-63
    CrossrefPubMedGoogle Scholar
  • 146 Kalmar JH, Gaudino EA, Moore NB et al. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychology 2008; 22: 442-449
    CrossrefPubMedGoogle Scholar
  • 147 Mitchell AJ, Kemp S, Benito-León J et al. The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatr 2010; 22: 2-13
    CrossrefPubMedGoogle Scholar
  • 148 Grasso MG, Troisi E, Rizzi F et al. Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study. Mult Scler 2005; 11: 719-724
    CrossrefPubMedGoogle Scholar
  • 149 Langdon DW, Thompson AJ. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999; 5: 94-100
    CrossrefPubMedGoogle Scholar
  • 150 Feinstein A. Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci 2006; 245: 63-66
    CrossrefPubMedGoogle Scholar
  • 151 Feinstein A. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281
    CrossrefPubMedGoogle Scholar
  • 152 Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 2008; 14: 691-724
    PubMedGoogle Scholar
  • 153 Haase CG, Tinnefeld M, Lienemann M et al. Depression and cognitive impairment in disability-free early multiple sclerosis. Behav Neurol 2003; 14: 39-46
    CrossrefPubMedGoogle Scholar
  • 154 Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469-475
    CrossrefPubMedGoogle Scholar
  • 155 Christodoulou C, Melville P, Scherl WF et al. Negative affect predicts subsequent cognitive change in multiple sclerosis. J Int Neuropsychol Soc 2009; 15: 53-61
    CrossrefPubMedGoogle Scholar
  • 156 Diamond BJ, Johnson SK, Kaufman M et al. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol 2008; 23: 189-199
    CrossrefPubMedGoogle Scholar
  • 157 Bruce JM, Arnett PA. Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 2004; 26: 200-214
    CrossrefPubMedGoogle Scholar
  • 158 Julian L, Merluzzi NM, Mohr DC. The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Mult Scler 2007; 13: 81-86
    CrossrefPubMedGoogle Scholar
  • 159 Kinsinger SW, Lattie E, Mohr DC. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology 2010; 24: 573-580
    CrossrefPubMedGoogle Scholar
  • 160 Lester K, Stepleman L, Hughes M. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30: 177-186
    CrossrefPubMedGoogle Scholar
  • 161 Hautzinger R, De Jong-Meyer R. Depressionen. In: Reinecker H, Hrsg. Lehrbuch der Klinischen Psychologie und Psychotherapie. Göttingen: Hogrefe; 2003
    Google Scholar
  • 162 Fisk JD, Pontefract A, Ritvo PG et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14
    CrossrefPubMedGoogle Scholar
  • 163 Pittion-Vouyovitch S, Debouverie M, Guillemin F et al. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45
    CrossrefPubMedGoogle Scholar
  • 164 Bol Y, Duits AA, Hupperts RMM et al. The psychology of fatigue in patients with multiple sclerosis: a review. J Psychosom Res 2009; 66: 3-11
    CrossrefPubMedGoogle Scholar
  • 165 Noll KR. Predictors of quality of life in multiple sclerosis: relationships between cognitive, physical, and subjective measures of disease burden. Im Internet: http://repositories.tdl.org/utswmed-ir/bitstream/handle/2152.5/951/NollKyle.pdf?sequence=2
    Google Scholar
  • 166 Morrow SA, Weinstock-Guttman B, Munschauer FE et al. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler 2009; 15: 998-1005
    CrossrefPubMedGoogle Scholar
  • 167 Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934-939
    PubMedGoogle Scholar
  • 168 Schwid SR, Tyler CM, Scheid EA et al. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler 2003; 9: 503-508
    CrossrefPubMedGoogle Scholar
  • 169 Bol Y, Duits AA, Hupperts RMM et al. The impact of fatigue on cognitive functioning in patients with multiple sclerosis. Clin Rehabil 2010; 24: 854-862
    CrossrefPubMedGoogle Scholar
  • 170 Parmenter BA, Denney DR, Lynch SG. The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler 2003; 9: 111-118
    CrossrefPubMedGoogle Scholar
  • 171 Schreiber H, Kiltz K, Lang M et al. Fatigue, Kognition und Persönlichkeit bei Patienten mit RRMS. Nervenarzt 2010; 81: 39-40
    PubMedGoogle Scholar
  • 172 Baumstarck-Barrau K, Simeoni MC, Reuter F et al. Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study. BMC Neurol 2011; 11: 17
    CrossrefPubMedGoogle Scholar
  • 173 Glanz BI, Healy BC, Rintell DJ et al. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci 2010; 290: 75-79
    CrossrefPubMedGoogle Scholar
  • 174 Ozakbas S, Idiman E, Kaya D et al. Effects of mitoxantrone treatment on cognitive and physical disability in patients with multiple sclerosis. Neurology 2008; 70 (Suppl. 01) P02
    CrossrefPubMedGoogle Scholar
  • 175 Schröder A, Klotz P, Lee DH et al. Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: a pilot analysis. Clin Neurol Neurosurg 2011; 113: 527-530
    CrossrefPubMedGoogle Scholar
  • 176 Piehl F, Holmén C, Hillert J et al. Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci 2011; 31: 289-293
    CrossrefPubMedGoogle Scholar
  • 177 Iaffaldano P, Viterbo RG, Paolicelli D et al. Impact of Natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS ONE 2012; 7: e35843
    CrossrefPubMedGoogle Scholar
  • 178 Polman CH, O'Connor PW, Havrdova E et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006; 354: 899-910
    CrossrefPubMedGoogle Scholar
  • 179 Rinaldi F, Calabrese M, Seppi D et al. Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis. Mult Scler 2012; 18: 1760-1762
    CrossrefPubMedGoogle Scholar
  • 180 Vass K. Natalizumab: Neuer Standard der Therapieeffektivität?. Journal für Neurologie, Neurochirurgie und Psychiatrie 2010; 11: 30-36
    PubMedGoogle Scholar
  • 181 Christodoulou C, MacAllister WS, McLinskey NA et al. Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?. CNS Drugs 2008; 22: 87-97
    CrossrefPubMedGoogle Scholar
  • 182 Krupp LB, Christodoulou C, Melville P et al. Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 2011; 76: 1500-1507
    CrossrefPubMedGoogle Scholar
  • 183 O’Carroll CB, Woodruff BK, Locke DE et al. Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic. Neurologist 2012; 18: 51-54
    CrossrefPubMedGoogle Scholar
  • 184 Rosti-Otajärvi E, Hämäläinen P. Rehabilitation for cognitive dysfunctions in persons suffering of Multiple Sclerosis (MS). Cochrane Database Syst Rev 2011; 11
    PubMedGoogle Scholar
  • 185 Thomas PW, Thomas S, Hillier C et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006; 1
    PubMedGoogle Scholar